BioMérieux stock breaks through 75.80 € and advances in a declining SBF 120
bioMérieux stands out during a challenging session for European markets. The in vitro diagnostics specialist breaks through a closely watched technical threshold during the session, against the backdrop of a SBF 120 losing ground amid persistent geopolitical tensions in the Gulf.
A resistance breakthrough that consolidates the stock's monthly rebound
The bioMérieux share gains 1.98% to 77.10 € during the session, after closing the previous day at 75.60 €. Even more significantly: the stock broke through its resistance at 75.80 € upward during the day and is maintaining this level, a technical signal that chartists are closely monitoring. This movement is part of a positive short-term dynamic, with a gain of nearly 12% over the past month and nearly 4% over the week.
The stock is advancing while the SBF 120 declines by 0.29% during the session, which places it among the strongest gainers in the index (13th rank out of 120 members). The VIX, an indicator of implied volatility in American markets, is also easing to 15.3, down from 16.34 the previous day, reflecting lower risk aversion on a global scale during this session.
An RSI in positive territory, but the 200-day MA remains a distant obstacle at nearly 86 €
On the indicators side, bioMérieux is trading above its short and medium-term moving averages: the price exceeds the 20-day MA (74.03 €) by 4.15% and the 50-day MA (72.14 €) by nearly 7%, confirming the recent upward momentum. The RSI at 60 remains in positive territory without reaching overbought levels, theoretically leaving room for further gains. The situation is more nuanced over a longer horizon: the 200-day MA at 86.63 € remains still 11% above the current price, reminding that the stock still shows a decline of 33.4% over twelve months.
The analysts' views on the value constitute another benchmark to follow in order to gauge the potential for recovery. The next resistance to watch is set at 101 €, representing a gap of more than 30% from the current price, while the support at 69 € offers a floor in case of a reversal.
